Faculty Disclosures
| Ronald Schondorf, MD |
No disclosure on file
|
| Roy L. Freeman, MD |
Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Freeman has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurobo. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Freeman has stock in Neurobo. Dr. Freeman has stock in Cutaneous NeuroDiagnostics. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. |
| Paola Sandroni, MD, PhD, FAAN |
Dr. Sandroni has nothing to disclose. |
|
No disclosure on file
|
| Steven Vernino, MD, PhD, FAAN |
Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Dysautonomia International. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities. |
| Carl-Albrecht Haensch, MD |
No disclosure on file
|
| Christopher H. Gibbons, MD, FAAN |
Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has stock in CND Life Sciences. Dr. Gibbons has received publishing royalties from a publication relating to health care. Dr. Gibbons has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Advisor with Department of Justice. |
| Thu Nguyen, MD |
No disclosure on file
|
| Phillip A. Low, MD, FAAN |
Dr. Low has nothing to disclose. |
| Valeria Iodice |
The institution of Valeria Iodice has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance . The institution of Valeria Iodice has received research support from ACT, UCL. |
| Richard Imrich |
No disclosure on file
|
| David S. Goldstein, MD, PhD |
Dr. Goldstein has received publishing royalties from a publication relating to health care. |
| Oladi S. Bentho, MD |
Dr. Bentho has nothing to disclose. |
| Nobutoshi Kawamura |
No disclosure on file
|
| Ann M. Schmeichel |
Ann M. Schmeichel has nothing to disclose. |
| Eduardo E. Benarroch, MD, FAAN |
Dr. Benarroch has nothing to disclose. |
| Joseph E. Parisi, MD |
Dr. Parisi has nothing to disclose. |
| Joel I. Shenker, MD, PhD, FAAN |
Dr. Shenker has received personal compensation for serving as an employee of R3 continuum. Dr. Shenker has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for attorneys. |
| Sushma R. Yerram, MD |
Dr. Yerram has nothing to disclose. |
| Simon Akerman, PhD |
No disclosure on file
|
| Jorge G. Ortiz-Garcia, MD, FAAN |
Dr. Ortiz-Garcia has nothing to disclose. |
| Maggie W. Waung, MD, PhD |
No disclosure on file
|
| Eugene L. Scharf, MD |
The institution of Dr. Scharf has received research support from American Brain Foundation. The institution of Dr. Scharf has received research support from NIH. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Grand Rounds. Dr. Scharf has a non-compensated relationship as a Steering committee with Johnson and Johnson that is relevant to AAN interests or activities. |
| Rochelle T. Sweis, DO |
No disclosure on file
|